Compare Amphastar Pharmaceuticals Inc (AMPH) vs Cisco Systems Inc (CSCO) Price & Performance

AMPH trades at $20.78, up 4.9% today, with a bullish technical signal supported by moving averages. The stock shows mixed earnings performance with Q2 2026 beating estimates but Q1 and Q4 2025 missing. Fundamentals remain solid with a 10.76% net margin and reasonable valuation at 12.02 P/E. Recent news highlights Q2 2026 results and strategic shift toward proprietary drugs.

Outlook is cautiously optimistic with growth supported by new product launches, though regulatory risks and earnings volatility pose challenges. Analyst sentiment is mixed with 25% buy ratings but majority hold recommendations. The stock offers value but requires monitoring of FDA developments and earnings consistency.

Cisco Systems (CSCO) trades at $121.43, up 0.45% today and near its 52-week high, supported by a bullish technical outlook and strong earnings beats. The stock's valuation is elevated with a P/E of 40.48 and P/S of 7.97, but profitability remains solid with a 64.33% gross margin. Recent news highlights Cisco's strategic push into AI cybersecurity, with new partnerships and product launches driving positive sentiment.

The outlook is positive given analyst consensus and AI-driven growth initiatives, but risks include high valuation and competitive pressures. Upside to the $133.25 price target is plausible if execution continues, though investors should monitor debt levels and margin trends.